Skip to main content

The Significance Of Galectin-3 Expression in the Immunocytochemical Evaluation of Thyroid Fine Needle Aspiration Cytology

Abstract

The aim of this study is to evaluate the significance of immunohistochemical expression of Galectin-3 in the differential diagnosis of benign and malignant thyroid nodules. We studied the fine needle aspiration specimens of 38 patients who had evaluated for nodular goiter and undergone a thyroid surgery between 2004–2005. Slides had been stained immunocytochemically with Galectin-3. The cytoplasmic staining of Galectin-3 was analyzed. Three cases of five follicular carcinomas had positive staining for Galectin-3, while two had not. Two cases with follicular adenomas were negative for Galectin-3. Five cases of six papillary carcinomas had positive staining for Galectin-3, while one case (the case with a papillary microcarcinoma) had not. The single cases with medullary and anaplastic carcinomas were negative for Galectin-3. None of the cases with a benign thyroid pathology had positive staining for Galectin-3. Galectin-3 immunocytochemical staining, had a sensitivity of 61.5%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 83.3% for thyroid malignancies. For the evaluation of follicular neoplasm, Galectin-3 immunocytochemical staining had a sensitivity of 60%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 50%. Galectin-3 expression in thyrocytes is a strong indicator of a malignant proliferative lesion especially for papillary and to an extent in follicular thyroid neoplasms. Galectin-3 could be used as a supplementary marker for cytological diagnosis.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A (1999) Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 17:3494–3502

    PubMed  CAS  Google Scholar 

  2. Nunez C, Mendelsohn G (1989) Fine-needle aspiration and needle biopsy of the thyroid gland. Pathol Annu 24:161–198

    PubMed  Google Scholar 

  3. Gharib H (1994) Fine-needle aspiration biopsy of thyroid nodules: advantages, limitations and effect. Mayo Clin Proc 69:44–49

    PubMed  CAS  Google Scholar 

  4. Segura MEA, Magalhaes AV (2005) Galectin-3 immunostaining in the thyroid neoplasms. J Bras Patol Med Lab 41:341–346

    Article  CAS  Google Scholar 

  5. Caraway NP, Sneige N, Saman NA (1993) Diagnostic pitfalls in thyroid fine-needle aspiration: a review of 394 cases. Diagn Cytopathol 9:345–350

    PubMed  Article  CAS  Google Scholar 

  6. Chiarotti L, Berlingieri MT, De Rosa P et al (1992) Increased expression of the negative growth factor, galactoside-binding protein gene, in transformed thyroid cells and in human thyroid carcinomas. Oncogene 71:2507–2511

    Google Scholar 

  7. Inohara H, Akahani S, Koths K, Raz A (1996) Interactions between galectin-3 and Mac-2-binding protein mediate cell–cell adhesion. Cancer Res 56:4530–4534

    PubMed  CAS  Google Scholar 

  8. Inohara H, Raz A (1995) Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. Cancer Res 55:3267–3271

    PubMed  CAS  Google Scholar 

  9. Bartolazzi A, Gasbarri A, Papotti M et al (2001) Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357:1644–1650

    PubMed  Article  CAS  Google Scholar 

  10. Inohara H, Honjo Y, Yoshii T et al (1999) Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 85:2475–2484

    PubMed  Article  CAS  Google Scholar 

  11. Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M, Sinadinovic J (1998) Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res 18:2637–2641

    PubMed  CAS  Google Scholar 

  12. Schlinkert RT, van Heerden JA, Goelnerr JR et al (1997) Factors that predict malignant thyroid lesions when fine-needle aspiration is “suspicious for follicular neoplasm”. Mayo Clin Proc 72:913–916

    PubMed  Article  CAS  Google Scholar 

  13. Tuttle RM, Lemar H, Burch HB (1998) Clinical features associated with an increased risk of thyroid malignancy in patients follicular neoplasia by fine-needle aspiration. Thyroid 8:377–383

    PubMed  Article  CAS  Google Scholar 

  14. Xu XC, El-Naggar AK, Lotan R (1995) Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications. Am J Pathol 147:815–822

    PubMed  CAS  Google Scholar 

  15. Kim MJ, Kim HJ, Hong SJ, Shong YK, Gong G (2006) Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions. Acta Cytol 50:28–34

    PubMed  Google Scholar 

  16. Mehrotra P, Okpokam A, Bouhaidar R et al (2004) Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Histopathology 45:493–500

    PubMed  Article  CAS  Google Scholar 

  17. Kovacs RB, Foldes J, Winkler G, Bodo M, Sapi Z (2003) The investigation of galectin-3 in diseases of the thyroid gland. Eur J Endocrinol 149:449–453

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Safak Ersoz.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ersoz, S., Sert, H., Yandi, M. et al. The Significance Of Galectin-3 Expression in the Immunocytochemical Evaluation of Thyroid Fine Needle Aspiration Cytology. Pathol. Oncol. Res. 14, 457 (2008). https://doi.org/10.1007/s12253-008-9041-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12253-008-9041-0

Keywords

  • Thyroid neoplasms
  • Galectin-3